GSK
2 years ago ⋅ English ⋅ 6 min read
Newsroom
GSK receives positive CHMP opinion recommending approval of Jemperli (dostarlimab) plus chemotherapy as a new frontline treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer

For media and investors only- If approved, dostarlimab would become the first new frontline treatment option in the European Union (EU) in decades and the only immuno-oncology combinati... Read More
GSK
2 years ago ⋅ English ⋅ 6 min read
Newsroom
GSK presents scientific advances to improve patient outcomes at the American Association for the Study of Liver Diseases’ The Liver Meeting® 2023

For media and investors only- New data from the B-Together phase IIb trial assessing the potential of a sequential treatment regimen of bepirovirsen followed by pegylated interferon alp... Read More
GSK
2 years ago ⋅ English ⋅ 8 min read
Newsroom
GSK and ViiV Healthcare to present scientific advancements in their industry-leading infectious diseases portfolio at IDWeek 2023

For media and investors only- First scientific presentation of RSV vaccine efficacy and safety data over two seasons- New public health impact modelling study data on meningococcal B im... Read More
GSK
2 years ago ⋅ English ⋅ 5 min read
Newsroom
GSK and Zhifei announce exclusive strategic vaccine partnership in China

For media and investors only- Partnership will significantly extend availability of Shingrix in China with co-promotion to healthcare professionals and over 30,000 points of vaccination... Read More
GSK
2 years ago ⋅ English ⋅ 5 min read
Newsroom
GSK survey finds parents know less about meningitis compared to some other childhood diseases

For media and investors only- New multi-country survey finds 93% of parents couldn’t identify all three of the most common meningitis symptoms. 1- While 88% considered meningitis... Read More
GSK
2 years ago ⋅ English ⋅ 2 min read
Newsroom
GSK announces Wendy Becker to join the Board as Non-Executive Director

For media and investors onlyGSK plc (LSE/NYSE: GSK) has today announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with effect from 1 October 2023.... Read More